Patents Assigned to Cognition Therapeutics, Inc.
  • INHIBITORS OF COGNITIVE DECLINE
    Publication number: 20140371324
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: June 2, 2014
    Publication date: December 18, 2014
    Applicant: COGNITION THERAPEUTICS, INC.
    Inventors: Gilbert M. RISHTON, Susan CATALANO
  • Inhibitors of cognitive decline
    Patent number: 8765816
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: July 1, 2014
    Assignee: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • ISOLATED COMPOUNDS FROM TURMERIC OIL AND METHODS OF USE
    Publication number: 20140080916
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods for treatment, inhibition, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: February 1, 2012
    Publication date: March 20, 2014
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • INHIBITORS OF COGNITIVE DECLINE
    Publication number: 20120129945
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: August 2, 2010
    Publication date: May 24, 2012
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • INHIBITORS OF COGNITIVE DECLINE
    Publication number: 20120095105
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: April 6, 2010
    Publication date: April 19, 2012
    Applicant: COGNITION THERAPEUTICS, INC.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • Inhibitors of cognitive decline
    Patent number: 7723377
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and Alzheimer's disease with a derivative of ginger oil are also provided. Also provided is a method of conditioning biological extracts, such as a medicinal plant extract, by a reductive amination process to give nitrogen-containing derivatives.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: May 25, 2010
    Assignee: Cognition Therapeutics, Inc.
    Inventors: Gilbert M Rishton, Hiromi Arai, Zoya Kai, Cody Lee Fullenwider, Kristin Beierle